ES2054716T3 - Bis-naftalimidas, su obtencion y empleo. - Google Patents

Bis-naftalimidas, su obtencion y empleo.

Info

Publication number
ES2054716T3
ES2054716T3 ES88103097T ES88103097T ES2054716T3 ES 2054716 T3 ES2054716 T3 ES 2054716T3 ES 88103097 T ES88103097 T ES 88103097T ES 88103097 T ES88103097 T ES 88103097T ES 2054716 T3 ES2054716 T3 ES 2054716T3
Authority
ES
Spain
Prior art keywords
bis
obtaining
naftalimidas
employment
naftalimides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88103097T
Other languages
English (en)
Inventor
Brana Miguel Dr Fernandez
Berlanga Jose Maria Castellano
Gerhard Dr Keilhauer
Erich Dr Schlick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of ES2054716T3 publication Critical patent/ES2054716T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBEN BIS-NAFTALIMIDAS DE FORMULA (I), EN LA QUE X1 A X4 TIENEN EL SIGNIFICADOQ UE SE INDICA EN LA DESCRIPCION, ASI COMO SU OBTENCION. LOS COMPUESTOS RESULTAN ADECUADOS PARA COMBATIR ENFERMEDADES.
ES88103097T 1987-03-10 1988-03-02 Bis-naftalimidas, su obtencion y empleo. Expired - Lifetime ES2054716T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873707651 DE3707651A1 (de) 1987-03-10 1987-03-10 Bis-naphthalimide, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2054716T3 true ES2054716T3 (es) 1994-08-16

Family

ID=6322686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88103097T Expired - Lifetime ES2054716T3 (es) 1987-03-10 1988-03-02 Bis-naftalimidas, su obtencion y empleo.

Country Status (6)

Country Link
US (1) US4874863A (es)
EP (1) EP0281902B1 (es)
JP (1) JP2604783B2 (es)
AT (1) ATE90345T1 (es)
DE (2) DE3707651A1 (es)
ES (1) ES2054716T3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
US5461176A (en) * 1991-03-27 1995-10-24 The Du Pont Merck Pharmaceutical Company Processes for preparing bis-naphthalimides containing amino-acid derived linkers
US5329048A (en) * 1991-03-27 1994-07-12 The Dupont Merck Pharmaceutical Company Process of preparing tetraamino intermediates
US5206250A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amide and thioamide linkers as anticancer agents
JPH07501822A (ja) * 1991-12-11 1995-02-23 デュポン・ファーマシュウティカルズ・カンパニー 抗癌剤として有用な高度に水溶性のビス−ナフタルイミド
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5376664A (en) * 1992-07-27 1994-12-27 The Du Pont Merck Pharmaceutical Company Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
DE4232739A1 (de) * 1992-09-30 1994-03-31 Knoll Ag Neue asymmetrisch substituierte bis-Naphthalimide
US5359070A (en) * 1993-02-11 1994-10-25 The Du Pont Merck Pharmaceutical Company Unsymmetrical bis-imides as anticancer agents
US5416089A (en) * 1993-06-24 1995-05-16 The Du Pont Merck Pharmaceutical Company Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
IL110460A (en) * 1993-08-18 2001-01-11 Basf Ag Bite-naphthalimides, their preparation and pharmaceutical preparations containing them
WO1995008539A1 (en) * 1993-09-24 1995-03-30 The Du Pont Merck Pharmaceutical Company Improved methods for preparing bis-imide compounds
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
WO1995029895A1 (en) * 1994-04-28 1995-11-09 Knoll Aktiengesellschaft Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
US5604095A (en) * 1994-07-22 1997-02-18 Cancer Therapy & Research Center Unsymmetrically linked bisnaphthalimides as antitumor agents
US5561042A (en) * 1994-07-22 1996-10-01 Cancer Therapy And Research Center Diamine platinum naphthalimide complexes as antitumor agents
US5641782A (en) * 1995-02-16 1997-06-24 The Dupont Merck Pharmaceutical Company 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
DK0930883T3 (da) * 1996-10-21 2006-05-22 Nps Allelix Corp Neurotrofinantagonister til behandling af epilepsi, Alzheimers sygdom og smerte
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US7605125B2 (en) * 2002-02-27 2009-10-20 The United States Of America As Represented By The Department Of Health And Human Services DNA-binding polyamide drug conjugates
US6979684B1 (en) 2004-06-30 2005-12-27 Council Of Scientific And Industrial Research Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof
JP4638485B2 (ja) * 2004-06-30 2011-02-23 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ ピペラジン部分により結合したピロロ［２，１−ｃ］［１，４］ベンゾジアゼピン−ナフタルイミド結合体及びそれを調製するための方法
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
WO2006060533A2 (en) 2004-12-01 2006-06-08 Genentech, Inc. Conjugates of 1, 8-bis-naphthalimides with an antibody
EP1931664A4 (en) 2005-09-15 2010-12-08 Painceptor Pharma Corp PROCESS FOR MODULATING NEUROTROPHINE-MEDIATED ACTIVITY
PT103503B (pt) 2006-06-19 2009-05-18 Univ Do Porto Novos derivados do bisnaftalimidopropil, processo para a sua preparação, composições farmacêuticas que os contêm e sua utilização em doenças cancerígenas e parasitárias, nomeadamente leishmanioses, tripanossomíases e malária.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146720A (en) * 1976-10-27 1979-03-27 Laboratorios Made, S.A. N-aminoethyl-substituted-3-nitronaphthalimides
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
US4499266A (en) * 1983-04-01 1985-02-12 Warner-Lambert Company 3,6-Dinitro-1,8-naphthalimides

Also Published As

Publication number Publication date
DE3881544D1 (de) 1993-07-15
JPS63230671A (ja) 1988-09-27
JP2604783B2 (ja) 1997-04-30
EP0281902B1 (de) 1993-06-09
EP0281902A1 (de) 1988-09-14
ATE90345T1 (de) 1993-06-15
US4874863A (en) 1989-10-17
DE3707651A1 (de) 1988-09-22

Similar Documents

Publication Publication Date Title
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
AR221094A1 (es) Derivados de n-((pirimidin o triazin)-aminocarbonil)-2-carbonil-benceno-sulfonamida,procedimiento para obtenerlos,compuesto empleado como intermedio,procedimiento para obtenerlo y composicion para el control de la vegetacion indeseable que contiene los nuevos derivados
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
MX9300977A (es) Compuetos heterobiciclicos.
MX9307974A (es) Nuevos derivados de acido hidroxiiminoalquilindolcarboxilico, su obtencion y uso.
ES2054649T3 (es) 2-aminotetralinas basicas substituidas.
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2056854T3 (es) Tiadiazinonas.
ES2061559T3 (es) Triazolinonas substituidas.
ES2038337T3 (es) 2,2-difluorociclopropiletano, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
ES2073393T3 (es) Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
ES2046218T3 (es) Derivados de acidos piridin-2,4- y -2,5-dicarboxilicos, procedimientos para su produccion, aplicacion de los mismos asi como medicamentos a base de estos compuestos.
ES2032317T3 (es) Derivados de quinazolina tetraciclicos, obtencion y empleo.
ES2077878T3 (es) Derivados substituidos de amidas de aminoacidos, su obtencion y su empleo como fungicidas.
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 281902

Country of ref document: ES